🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to share I’ve joined Profluent as CBO! I’m already amazed at how Ali Madani and our team are bridging #AI & #CRISPR to revolutionize disease treatment. And to add to the good news, today we announced $35M in additional funding to fuel our growth. More 👇

Great read from Kyle LaHucik in Endpoints News 👇

At @Profluent, we’re committed to safely accelerating the development of #CRISPR therapies for thousands of incurable diseases and are thrilled to unveil our #OpenCRISPR initiative, the world’s first open-source, #AI-generated gene editor. Let’s build together 💪

Today at #ASGCT2024, we are presenting on our AI-powered approach to custom-building de novo gene editors. Come see us! 🎤 Language Models Generate Novel Genome Editors from Scratch 📅 2 pm EST in Ballroom 1 #AI #GenerativeAI #ProteinDesign #CRISPR

Thrilled to join some inspiring and talented women in #cellandgenetherapy on The CGT Circle’s mentoring panel in Boston tomorrow. Don’t miss it! ➡️ linkedin.com/posts/the-cgt-…

Great speaking with @DSLevine on The Bio Report podcast about why #generativeAI is perfectly suited to advance the field of #geneediting and solve some of society’s most challenging problems. Give it a listen: 👉 thebioreport.podbean.com/e/using-genera…

Thrilled to share this exciting research from our team detailing proseLM, a novel method that incorporates biological context into sequence design, to finetune our functional outputs. Learn more 👇

So great speaking with Matthew Pillar on the Business of Biotech podcast about my connection to rare disease, the potential of AI for next generation CRISPR medicines, and why we’re flipping the drug development paradigm upside down at John Stephen Scholl.👇 youtube.com/watch?v=oUqFck…

Excited to share perspectives on the role of AI in transforming drug discovery during an insightful panel discussion this Thursday Oct 3! Get on the waitlist now:  bit.ly/4ekPZXU #AI #JohnsonAndJohnson #CaliforniaLifeSciences

Thrilled to share this exciting research from our team detailing our new Protein2PAM model and previewing what’s to come with our suite of models for engineering protein-DNA interactions and authoring new proteins. If you want to learn more, I'll be at JP Morgan next week!

At Logan ready to ✈️ to San Francisco for #JPM2025! Wonder who I'll recognize on the plane... 😉 If you're interested in learning more about Profluent's AI-first protein design capabilities or our recent #Protein2PAM release, let's find time to chat.

Heading to Rome today for the Alliance for Regenerative Medicine (ARM) #CGMed25 and excited to join Sadik, Dr. Maryam Mokhtarzadeh, Hilary Schultz, and moderator John Hadden II to explore not-for-profit innovation of gene therapies for rare disease. More info: meetingonthemed.com

Profluent just launched its most powerful foundation model yet - and there are endless possibilities to create solutions in biomedicine, agriculture, climate, and beyond. Interested in licensing one of Profluent’s models or molecules? 👉 profluent.bio/showcase/proge…

Thrilled to head to NOLA next week for #ASGCT2025! Reach out if you want to meet or catch up.